Nuformix plc (LON:NFX)
London · Delayed Price · Currency is GBP · Price in GBX 0.0925
-0.0025 (-2.70%)
Aug 15, 2025, 4:41 PM BST
Nuformix Market Cap
Nuformix has a market cap or net worth of 1.85 million as of August 15, 2025. Its market cap has increased by 28.75% in one year.
Market Cap
1.85M
Enterprise Value
1.75M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
0.09
Market Cap Chart
Since October 16, 2017, Nuformix's market cap has decreased from 17.28M to 1.85M, a decrease of -89.32%. That is a compound annual growth rate of -24.84%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 14, 2025 | 1.85M | 173.82% |
| Dec 31, 2024 | 674.17K | -72.13% |
| Dec 29, 2023 | 2.42M | 0.30% |
| Dec 30, 2022 | 2.41M | -63.56% |
| Dec 31, 2021 | 6.62M | -52.25% |
| Dec 31, 2020 | 13.86M | -68.32% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Oct 16, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 171.91B |
| GSK plc | 56.34B |
| Haleon | 31.86B |
| Smith & Nephew | 11.76B |
| ConvaTec Group | 4.64B |
| Hikma Pharmaceuticals | 3.95B |
| Oxford Nanopore Technologies | 2.04B |
| HUTCHMED (China) | 1.92B |